Related Experiment Video
Updated: May 5, 2026

Visualization of Intensity Levels to Reduce the Gap Between Self-Reported and Directly Measured Physical Activity
Published on: March 7, 2019
Physical activity, sedentary behavior and risk of inflammatory bowel disease: a prospective cohort study in the UK
Siqin Xia1,2, Jie Zhang3, Zixing Zhang1,2
1Department of Epidemiology and Biostatistics, School of Public Health, Anhui Medical University, Hefei, Anhui, 230032, China.
Background:
Evidence suggests that physical activity (PA) may mitigate chronic inflammation, while sedentary behavior (SB) could exacerbate gut dysbiosis-key mechanisms in inflammatory bowel disease (IBD). However, epidemiological data on their independent and joint associations with IBD risk remains inconsistent and inconclusive.
Objective:
This cohort study aimed to examine the separate and joint association of PA and SB with IBD risk.
Methods:
The research contained 355,021 people with no IBD at baseline in the UK Biobank. PA was measured using the International PA Questionnaire(IPAQ), calculating metabolic equivalent tasks (METs) min/wk based on the frequency and duration of walking, moderate, and vigorous activities. SB was assessed by self-reported total time spent driving, using computers, and watching television in a day. Using Cox proportional hazard models to evaluate the hazard ratios (HRs) and 95% confidence intervals (CIs) for IBD, Crohn's disease (CD) and ulcerative colitis (UC) risks, while restricted cubic splines (RCS) assessing nonlinear relationships.
Results:
During 13.6 years of follow-up, 2,242 incident IBD cases (664 CD and 1,481 UC) were recorded. Compared to the low level of PA, IBD risk was found to be lower for moderate and high PA, with HRs of 0.80 (95% CI: 0.72-0.89, p < 0.001) and 0.87 (95% CI: 0.78-0.98, p = 0.02), respectively. We also found a nonlinear correlation of PA with IBD risk (p < 0.05 for nonlinearity), with a moderate level of PA (~ 2000 MET min/wk) offering the lowest risk. Besides, each additional hour of SB per day increased IBD risk (HR: 1.03; 95% CI: 1.01-1.05; p < 0.001). The risk reduction from moderate and high levels of PA attenuated the adverse effects of long SB (≥ 6 h/day), decreasing the risk by 18% and 27%, respectively. The results of PA and SB together on IBD risk showed that participants with low PA and long SB have the highest IBD risk.
Conclusions:
The results revealed that promoting PA and reducing SB synergistically lower IBD risk. Individuals combining high PA with lowest SB time are at the lowest probability of developing IBD.
Related Concept Videos
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Inflammatory Bowel Disease I: Introduction
Inflammatory Bowel Disease II: Ulcerative Colitis
Inflammatory Bowel Disease III: Crohn's Disease

